Dr. Beth Scholz
Claim this profileBaylor Scott & White Medical Center - Temple
Studies Systemic Lupus Erythematosus
Studies Lupus
2 reported clinical trials
3 drugs studied
Area of expertise
1Systemic Lupus Erythematosus
ANA positive
anti-dsDNA positive
anti-Sm positive
2Lupus
ANA positive
anti-dsDNA positive
anti-Sm positive
Affiliated Hospitals
Clinical Trials Beth Scholz is currently running
Baricitinib
for Rheumatoid Arthritis
This trial compares the safety of two treatments for rheumatoid arthritis, focusing on the risk of blood clots. One treatment is baricitinib, an oral medication used for moderate to severe cases.
Recruiting3 awards Phase 43 criteria
Deucravacitinib
for Lupus
This trial is testing a new medication called deucravacitinib to see if it is safe and effective for people with moderate to severe lupus, a disease where the immune system attacks the body. The medication aims to reduce inflammation by targeting specific enzymes in the immune system.
Recruiting1 award Phase 3
More about Beth Scholz
Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Beth Scholz has experience with
- Deucravacitinib
- Baricitinib
- TNF Inhibitor
Breakdown of trials Beth Scholz has run
Systemic Lupus Erythematosus
Arthritis
Rheumatoid Arthritis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Beth Scholz specialize in?
Beth Scholz focuses on Systemic Lupus Erythematosus and Lupus. In particular, much of their work with Systemic Lupus Erythematosus has involved ANA positive patients, or patients who are anti-dsDNA positive.
Is Beth Scholz currently recruiting for clinical trials?
Yes, Beth Scholz is currently recruiting for 2 clinical trials in Temple Texas. If you're interested in participating, you should apply.
Are there any treatments that Beth Scholz has studied deeply?
Yes, Beth Scholz has studied treatments such as Deucravacitinib, Baricitinib, TNF Inhibitor.
What is the best way to schedule an appointment with Beth Scholz?
Apply for one of the trials that Beth Scholz is conducting.
What is the office address of Beth Scholz?
The office of Beth Scholz is located at: Baylor Scott & White Medical Center - Temple, Temple, Texas 76508 United States. This is the address for their practice at the Baylor Scott & White Medical Center - Temple.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.